Floatz logo

Atropine

Advanced HR+/HER2- Breast Cancer

MedSIRSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Advanced HR+/HER2- Breast Cancer cohort.

Asset / SponsorPhaseRating
Loperamide
MedSIR
Phase 2B
FILGRASTIM
MedSIR
Phase 2B
FULVESTRANT
Novartis Pharmaceuticals
Phase 1/2CCC
Letrozole
Novartis Pharmaceuticals
Phase 1/2CCC
LEUPROLIDE
Novartis Pharmaceuticals
Phase 1/2CC

View all 11 →

Same molecule, other indications

Atropine is also rated in:

Neuromuscular BlockadeDormant
BB
Indicative ·
70 / 100
View asset →
Obstructive Sleep ApneaDormant
BB
Indicative ·
68 / 100
View asset →
Cirrhosis and Chronic Liver DiseaseDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →